Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Lorenz, M; Hauser, AC; Püspök-Schwarz, M; Kotanko, P; Arias, I; Zodl, H; Kramar, R; Paschke, E; Voigtländer, T; Sunder-Plassmann, G.
Anderson-Fabry disease in Austria.
Wien Klin Wochenschr. 2003; 115(7-8):235-240 Doi: 10.1007/BF03040321 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Paschke Eduard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Fabry disease is an X-linked inherited inborn error of glycosphingolipid catabolism. The deficiency of alpha-galactosidase A leads to the deposition of glycosphingolipids primarily in lysosomes of blood vessel cells. In classically affected hemizygotes clinical manifestations include pain in the extremities, vessel ectasia (angiokeratoma) in skin and mucous membranes, ophthalmological abnormalities, and hypohidrosis. As disease progresses there is renal, cardiac, cerebral and vascular involvement, with most patients experiencing renal insufficiency, cardiac hypertrophy or stroke. Many female carriers of Fabry disease also have symptoms. Recently available enzyme replacement therapy has the potential to control or even reverse disease progression. The present analysis reports on five Austrian families with Fabry disease, cared for by nephrologists in June 2002. Furthermore we discuss potential indications for enzyme replacement therapy in patients maintained on renal replacement therapy.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Biopsy -
Chromosomes, Human, X -
Diagnosis, Differential -
Fabry Disease - diagnosis
Genes, Recessive - genetics
Heterozygote Detection - genetics
Humans - genetics
Isoenzymes - adverse effects
Kidney - pathology
Male - pathology
Middle Aged - pathology
Pedigree - pathology
Prognosis - pathology
Recombinant Proteins - adverse effects
Renal Dialysis - adverse effects
Sex Chromosome Aberrations - adverse effects
alpha-Galactosidase - adverse effects

Find related publications in this database (Keywords)
lysosomal storage diseases
Fabry disease
enzyme replacement therapy
end-stage renal disease
© Med Uni GrazImprint